Articles

Vaccine-related stocks moved sharply higher Wednesday as new human bird-flu cases were reported in the U.S. and Australia.

“We will share more details when there is a clearer path forward,” NASA says.

Oil futures finish lower for a third straight day as investors await official data on U.S. crude and product inventories.

Attorney David Boies argues that moving pot to Schedule III won’t remove the threat of prosecution for state-legal pot companies.

“Various participants mentioned a willingness to tighten policy further should risks to inflation materialize in a way that such an action became appropriate,” the minutes said.

A new poll is offering fresh evidence that the U.S. economy’s strong performance isn’t resonating with many Americans, even as numerous conventional economic indicators are encouraging.

Bonds would benefit if the Federal Reserve cuts rates more deeply next year than traders currently expect.

The last time the stock fell that much was July 27, 2022, when it fell 8.7%, according to Dow Jones Market Data. BofA says the stock is priced to perfection — meaning there’s only downside risk.

The S&P 500 is on track for its strongest first 100 trading days on record in an election year. Here’s what history says about strong starts for the stock market.

SunPower Corp. stock leads the way after the solar-power company unveiled a deal with Tesla for stationary batteries.

A low-cost index strategy tracking stocks with the highest risk-weighted returns has fared well during a period of high inflation and “clear, defined leadership” for the technology sector.

More than three out of four young adults prescribed GLP-1 drugs last year were women, new research shows–raising questions about how societal views of women’s weight may influence use of these medications and underscoring the need to better understand how the drugs may affect fertility, pregnancy, and longer-term health outcomes, researchers say.